Categories: News Features

‘Protein-based therapeutics are the future of pharma’


HYDERABAD, MARCH 14, 2014:

Protein-based therapeutics are tipped to be the most important segment in the pharma market in the near future, says Girish Sahni, Director of Chandigarh-based Institute of Microbial Technology.

These products are at present occupying an increasingly important position worldwide in medicine, he said, while delivering the Yellapragada Subba Row Memorial Lecture, titled ‘Four generations of clot busters: Evolution from affordable bio-generics to innovative bio-leaders’, at the University of Hyderabad.

Therapeutic proteins are proteins engineered in the lab for pharmaceutical use. For example, insulin was one of the first protein therapeutic introduced to treat diabetes.

These therapies are now used in treatment of cancer, anaemia, hepatitis, infectious diseases, and so on.

In India, the focus has been on developing biotechnologies by evolving improved process know-how and economies of scale, he said.

However, there is an opportunity to design newer, patentable biologics that can reposition the Indian bio-pharma experience to one of strategic advantage through process improvement on one hand and innovation in molecular design/redesign on the other, Sahni added.

He talked about the 15 years of applications-oriented work he carried out along with colleagues at the Chandigarh lab on the development of protein-based drugs, especially in the area of life-saving clot dissolvers.

Efforts to develop clot buster drugs began in the country in the mid-1990s.

Till then, such drugs were imported, and sold at comparatively high cost, varying between ₹5,000 for streptokinase and nearly ₹50,000 for tissue plasminogen activator for a single dose. Business Line

The Pharma Times News Bureau

Recent Posts

CARE Hospitals, Nampally, Hosts the 12th National Infection Prevention and Control (IPC) Certificate Program

Hyderabad, November 22, 2024: CARE Hospitals, Nampally, successfully hosted the 12th National Infection Prevention and Control (IPC)…

3 hours ago

61-Year-Old African Doctor morbidly Obese successfully treated for End-Stage Renal Disease via Robot-Assisted Kidney Transplant at Fortis Hospital Cunningham Road

Bengaluru, November 22, 2024: Fortis Hospital, Cunningham Road successfully performed a life-enhancing robot-assisted kidney transplant on 61-year-old…

3 hours ago

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

1 day ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

1 day ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

2 days ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

2 days ago